Abstract
Tumor hypoxia can influence the progression and metastasis of various cancers, including hepatocellular carcinoma (HCC). Clinical studies have indicated that hyperbaric oxygen may improve the prognosis and reduce complications in HCC patients; however, whether pulmonary function can influence the prognosis of HCC remains unknown. In this study, we found that pulmonary function was associated with clinicopathological features, including smoking, liver cirrhosis, tumor size Edmondson-Steiner grade, total operative blood loss and perioperative blood transfusion. Through Cox proportional hazard regression analysis, smoking, tumor number, tumor size, liver cirrhosis, total operative blood loss and pulmonary function were independent risk factors for overall survival (OS) and disease-free survival (DFS). In addition, poor pulmonary function was independently associated with shorter survival and increased HCC recurrence in patients. Notably, we also found that HCC with liver cirrhosis predicted worse prognosis. In summary, our study found pulmonary function could influence HCC progression. Improve pulmonary function may enhance the OS and DFS of patients with HCC.
References
Oct 2, 2002·Radiology·Makiko HayashiMasumi Kadoya
Feb 4, 2005·The Journal of Clinical Investigation·Ramón Bataller, David A Brenner
Jul 5, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Jul 18, 2006·Experimental Cell Research·Jean-Pascal PiretCarine Michiels
Apr 27, 2007·Cancer Metastasis Reviews·Richard Sullivan, Charles H Graham
Feb 15, 2008·Nature Reviews. Cancer·Robert G Bristow, Richard P Hill
Mar 24, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Bryan L CoppleJeon-Ok Moon
May 30, 2009·Journal of Cellular Biochemistry·Kai RuanGaoliang Ouyang
Dec 2, 2009·BMC Cancer·Chen-Xin DaiJia Fan
Oct 1, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Bryan L CoppleJeon-Ok Moon
Nov 12, 2010·Langenbeck's Archives of Surgery·Shinichi UenoShoji Natsugoe
Jan 22, 2011·Journal of Cellular and Molecular Medicine·Aude CarreauClaudine Kieda
May 25, 2011·Nature Reviews. Cancer·William R Wilson, Michael P Hay
Jun 8, 2011·Molecular Biology Reports·Zuo-Lin XiangJoe Y Chang
Jan 25, 2012·The Journal of Pharmacology and Experimental Therapeutics·Bryan L CoppleCallie Wentling
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Sep 3, 2013·Histology and Histopathology·Stefania CannitoMaurizio Parola
Jan 1, 2014·Japanese Journal of Clinical Oncology·Sheng-Li YangChao Wu
Feb 18, 2014·Gut·Jordi BruixVincenzo Mazzaferro
Jun 24, 2014·PloS One·Hai-Shan PengYi-Fei Chen
Aug 27, 2014·Journal of Hepatology·Garrick K WilsonJane A McKeating
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Mar 24, 2016·Proceedings of the National Academy of Sciences of the United States of America·Chuanzhao ZhangGregg L Semenza
Apr 25, 2016·Respiratory Investigation·Asuka MatsuzakiYoshinori Hasegawa
Aug 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Daniel M LewisSharon Gerecht
Aug 10, 2016·Cancer Research·Mei-Fong PangCeleste M Nelson
Aug 10, 2016·Cancer Cell·Young Chan ChaeDario C Altieri
Aug 18, 2016·Nature·Bernard ThienpontDiether Lambrechts
Jan 28, 2017·American Journal of Respiratory and Critical Care Medicine·Claus F VogelmeierAlvar Agustí
Apr 4, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Samer TohmeAllan Tsung
May 12, 2017·Oncotarget·Chu Chen, Tao Lou
Jun 8, 2017·Japanese Journal of Clinical Oncology·Yuki TajimaYuko Kitagawa
Jun 16, 2017·Clinical and Translational Gastroenterology·Ken LiuGeoffrey W McCaughan